Abstract
The prophylactic potency of topically applied human leukocyte interferon and human fibroblast interferon was compared in a monkey model with herpes simplex virus type 1-induced keratitis. Both interferons effectively prevented keratitis at 1.9 X 10(6) U of activity per ml but were ineffective at 1.9 X 10(3) U/ml. Slight differences between human leukocyte interferon and human fibroblast interferon observed at the level of 1.9 X 10(5) U/ml were not statistically significant.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cantell K., Hirvonen S., Mogensen K. E., Pyhälä L. Human leukocyte interferon: production, purification, stability, and animal experiments. In Vitro Monogr. 1974;(3):35–38. [PubMed] [Google Scholar]
- Edy V. G., Billiau A., De Somer P. Human fibroblast and leukocyte interferons show different dose-response curves in assay of cell protection. J Gen Virol. 1976 May;31(2):251–255. doi: 10.1099/0022-1317-31-2-251. [DOI] [PubMed] [Google Scholar]
- Havell E. A., Berman B., Ogburn C. A., Berg K., Paucker K., Vilcek J. Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2185–2187. doi: 10.1073/pnas.72.6.2185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Havell E. A., Vilcek J. Production of high-titered interferon in cultures of human diploid cells. Antimicrob Agents Chemother. 1972 Dec;2(6):476–484. doi: 10.1128/aac.2.6.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones B. R., Coster D. J., Falcon M. G., Cantell K. Topical therapy of ulcerative herpetic keratitis with human interferon. Lancet. 1976 Jul 17;2(7977):128–128. doi: 10.1016/s0140-6736(76)92850-6. [DOI] [PubMed] [Google Scholar]
- Kaufman H. E., Sugar J., Varnell E. D. Effect of exogenous interferon on herpetic keratitis in rabbits and monkeys. Invest Ophthalmol. 1973 May;12(5):378–380. [PubMed] [Google Scholar]
- Neumann-Haefelin D., Sundmacher R., Sauter B., Karges H. E., Manthey K. F. Effect of human leukocyte interferon on vaccinia-and herpes virus-infected cell cultures and monkey corneas. Infect Immun. 1975 Jul;12(1):148–155. doi: 10.1128/iai.12.1.148-155.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stewart II W. E., De Somer P., Edy V. G., Paucker K., Berg K., Ogburn C. A. Distinct molecular species of human interferons: requirements for stabilzation and reactivation of human leukocyte and fibroblast interferons. J Gen Virol. 1975 Mar;26(3):327–331. doi: 10.1099/0022-1317-26-3-327. [DOI] [PubMed] [Google Scholar]
- Sundmacher R., Neumann-Haefelin D., Cantell K. Letter: Interferon treatment of dendritic keratitis. Lancet. 1976 Jun 26;1(7974):1406–1407. doi: 10.1016/s0140-6736(76)93052-x. [DOI] [PubMed] [Google Scholar]
- Sundmacher R., Neumann-Haefelin D., Cantell K. Successful treatment of dendritic keratitis with human leukocyte interferon. A controlled clinical study. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1976 Nov 18;201(1):39–45. doi: 10.1007/BF00410146. [DOI] [PubMed] [Google Scholar]
- Sundmacher R., Neumann-Haefelin D., Manthey K. F., Müller O. Interferon in treatment of dendritic keratitis in humans: a preliminary report. J Infect Dis. 1976 Jun;133 (Suppl):A160–A164. doi: 10.1093/infdis/133.supplement_2.a160. [DOI] [PubMed] [Google Scholar]